Inogen, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INGN research report →
Companywww.inogen.com
Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
- CEO
- Kevin R. Smith
- IPO
- 2014
- Employees
- 766
- HQ
- Goleta, CA, US
Price Chart
Valuation
- Market Cap
- $171.65M
- P/E
- -6.96
- P/S
- 0.49
- P/B
- 0.95
- EV/EBITDA
- -18.28
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 48.73%
- Op Margin
- -8.81%
- Net Margin
- -7.08%
- ROE
- -12.90%
- ROIC
- -13.21%
Growth & Income
- Revenue
- $348.67M · 3.86%
- Net Income
- $-22,747,000 · 36.62%
- EPS
- $-0.85 · 44.08%
- Op Income
- $-30,207,000
- FCF YoY
- -93.21%
Performance & Tape
- 52W High
- $9.13
- 52W Low
- $5.34
- 50D MA
- $6.59
- 200D MA
- $7.04
- Beta
- 1.65
- Avg Volume
- 334.77K
Get TickerSpark's AI analysis on INGN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 6, 26 | Richardson Jason Andrew | other | 100,000 |
| Apr 6, 26 | Richardson Jason Andrew | other | 0 |
| Mar 1, 26 | Wright Mary E | other | 3,001 |
| Mar 1, 26 | Wright Mary E | other | 1,155 |
| Mar 1, 26 | Wright Mary E | other | 2,750 |
| Mar 1, 26 | Wright Mary E | other | 1,058 |
| Mar 1, 26 | Wright Mary E | other | 1,351 |
| Mar 1, 26 | Wright Mary E | other | 520 |
| Mar 1, 26 | Wright Mary E | other | 1,755 |
| Mar 1, 26 | Wright Mary E | other | 675 |
Our INGN Coverage
We haven't published any research on INGN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate INGN Report →